This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

2nd international conference in pharmacology

Conference highlighting the the newest findings in pharmacology with the purpose of exchanging ideas and bringing together research scientists, academics, industry specialists, doctors, pharmacists and students of life sciences.

19–20 Oct 2017

Abstracts deadline: 25 Sep 2017

Registration deadline: 17 Oct 2017

Riga, Latvia - View map

  • Overview
  • Event programme

Conference highlighting the the newest findings in pharmacology with the purpose of exchanging ideas and bringing together research scientists, academics, industry specialists, doctors, pharmacists and students of life sciences.

For full details please visit the International Conference in Pharmacology website.

Thursday 19 October 2pm – 5pm

  • The Guide to Pharmacology: a collaboration between the British Pharmacological Society (BPS) and the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR).
  • Can we put brakes on aging?
  • Treatment of Alzheimer's disease using small D-peptides
  • RGD as a putative active center of an oligopeptide lunasin
  • The 45th Anniversary of the Latvian Society of Pharmacology
  • In commemoration of Modris Melzobs: the first president of Latvian Society of Pharmacology
  • The forty five years of the Latvian Society of Pharmacology

Friday 20 October 8.30am – 3pm

  • Developing new therapies for rare Batten Disease
  • Oncolytic Cancer Virotherapy with Rigvir
  • The impact of cancer extracellular vesicles on mesenchymal stem cell phenotype
  • Monitoring of ligand binding to receptors using fluorescence anisotropy based assay
  • Cannabinoids - complexity at every level on the path to therapeutic exploitation: plant cannabinoids; endocannabinoids; target receptors; transforming enzymes
  • Pharmacological modulation of plasma bilirubin concentration to achieve neuroprotective action
  • Extracellular vesicles as potential novel therapeutic tools against neurodegenerative diseases
  • Neuroprotective effects of GABA receptor agonists
  • Traumatic brain injury-induced cognitive decline: mechanisms and treatment options
  • Overcoming drug barrier of the brain by claudin peptidomimetics
  • How, Why, and When to Train the Pharmacological Targets for Prevention of Second Brain Injuries?
  • Aβ oligomer eliminating D-enantiomeric peptides enhance cognition and impede neurodegeneration even by oral application

For the full programme please visit the International Conference in Pharmacology website.